{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:10:04Z","timestamp":1784549404657,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13749-x","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:53:27Z","timestamp":1780761207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for mucormycosis among diabetic individuals, Bathinda, Punjab: a case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Gopi","family":"Kumbha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Monya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep Singh","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikasdeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya Swaroop","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivanantham","family":"Krishnamoorthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzin","family":"Dikid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"13749_CR1","unstructured":"WHO, Keyfacts. Emergencies. Coronavirus disease (COVID-19). Mucormycosis. Available from: https:\/\/www.who.int\/india\/home\/emergencies\/coronavirus-disease-(covid-19)\/mucormycosis (accessed on 19.04.2024)."},{"key":"13749_CR2","doi-asserted-by":"crossref","unstructured":"Patel SN, Shah S, Panchal J, Desai C, Upadhya IB, Patel M, Panchal JR. Spotlight on the mucormycosis outbreak: a deadly fungal infection that followed the COVID-19 pandemic. Cureus. 2023;15(2).","DOI":"10.7759\/cureus.35095"},{"key":"13749_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","volume":"6","author":"A Skiada","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: An update. J Fungi. 2020;6:265.","journal-title":"J Fungi"},{"issue":"7","key":"13749_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/cid\/ciab726","volume":"74","author":"S Narayanan","year":"2022","unstructured":"Narayanan S, Chua JV, Baddley JW. Coronavirus disease 2019\u2013associated mucormycosis: risk factors and mechanisms of disease. Clin Infect Dis. 2022;74(7):1279\u201383.","journal-title":"Clin Infect Dis"},{"key":"13749_CR5","doi-asserted-by":"publisher","unstructured":"Qu J, Liu X, Quan M, Qiao F, Bilal H, Fang W, et al. Expert consensus on the prevention of secondary mucormycosis following respiratory viral infections. iFungi. 2026. https:\/\/doi.org\/10.26599\/iFungi.2026.9670007.","DOI":"10.26599\/iFungi.2026.9670007"},{"key":"13749_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/microorganisms10061209","volume":"10","author":"AK Pandit","year":"2022","unstructured":"Pandit AK, Tangri P, Misra S, Srivastava MVP, Bhatnagar S, Thakar A, Sikka K, Panda S, Vishnu VY, Singh RK, et al. Mucormycosis in COVID-19 Patients: A Case-Control Study. Microorganisms. 2022;10:1209. https:\/\/doi.org\/10.3390\/microorganisms10061209.","journal-title":"Microorganisms"},{"key":"13749_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11046-004-9483-1","volume":"159","author":"GM Vidyasagar","year":"2005","unstructured":"Vidyasagar GM, Hosmani N, Shivkumar D. Keratinophilic fungi isolated from hospital dust and soils of public places at Gulbarga, India. Mycopathologia. 2005;159:13\u201321.","journal-title":"Mycopathologia"},{"key":"13749_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/mmy\/myz081","volume":"58","author":"U Pamidimukkala","year":"2020","unstructured":"Pamidimukkala U, Sudhaharan S, Kancharla A, et al. Mucormycosis due to Apophysomyces species complex\u201425 years\u2019 experience at a tertiary care hospital in southern India. Med Mycol. 2020;58:425\u201333.","journal-title":"Med Mycol"},{"key":"13749_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhin.2004.10.011","volume":"60","author":"U Kelkar","year":"2005","unstructured":"Kelkar U, Bal AM, Kulkarni S. Fungal contamination of air conditioning units in operating theatres in India. J Hosp Infect. 2005;60:81\u20134.","journal-title":"J Hosp Infect"},{"key":"13749_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","volume":"69","author":"M Sen","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al. Members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 Study Group. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India\u2014Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69:1670\u201392.","journal-title":"Indian J Ophthalmol"},{"key":"13749_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/jof7040298","volume":"7","author":"TM John","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi. 2021;7:298.","journal-title":"J Fungi"},{"issue":"3","key":"13749_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.diabres.2006.01.008","volume":"73","author":"AM Tomlin","year":"2006","unstructured":"Tomlin AM, Tilyard MW, Dovey SM, Dawson AG. Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract. 2006;73(3):260\u20137. https:\/\/doi.org\/10.1016\/j.diabres.2006.01.008.","journal-title":"Diabetes Res Clin Pract"},{"key":"13749_CR13","unstructured":"Chander J. (2018). Textbook of medical mycology. 4th ed. New Delhi: Jaypee Brothers Medical Publishers. This textbook notes the occupational risks associated with fungal infections like mucormycosis in agricultural and construction settings. [Cross ref]."},{"key":"13749_CR14","unstructured":"Hern\u00e1ndez JL, Buckley CJ. Mucormycosis. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 31335084."},{"issue":"7","key":"13749_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cmi.2019.11.021","volume":"26","author":"A Patel","year":"2020","unstructured":"Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, Singh R, Shastri P, Umabala P, Sardana R, Kindo A. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26(7):944\u2013e9.","journal-title":"Clin Microbiol Infect"},{"key":"13749_CR16","doi-asserted-by":"crossref","unstructured":"Mishra Y, Prashar M, Sharma D, Kumar VP, Tilak TV. COVID-19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr. 2021;15(4):102196.","DOI":"10.1016\/j.dsx.2021.102196"},{"issue":"5","key":"13749_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634\u201353.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13749_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","volume":"5","author":"H Prakash","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019;5(1):26.","journal-title":"J Fungi"},{"key":"13749_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"T Sein","year":"2005","unstructured":"Sein T, Chiou CC, Chu JH, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis. 2005;41:634\u201353.","journal-title":"Clin Infect Dis"},{"key":"13749_CR20","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/B978-1-4557-4801-3.00260-5","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"DP Kontoyiannis","year":"2015","unstructured":"Kontoyiannis DP, Lewis RE. Agents of Mucormycosis and Entomophthoramycosis. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, Pa: Elsevier\/Saunders; 2015. pp. 2909\u201319.","edition":"8"},{"issue":"10","key":"13749_CR21","first-page":"1193","volume":"25","author":"S Yadav","year":"2021","unstructured":"Yadav S, Sharma A, Kothari N, Bhatia PK, Goyal S, Goyal A, Mucormycosis. A case series of patients admitted in non-COVID-19 intensive care unit of a tertiary care center during the second wave. Indian J Crit Care Medicine: Peer-reviewed Official Publication Indian Soc Crit Care Med. 2021;25(10):1193.","journal-title":"Indian J Crit Care Medicine: Peer-reviewed Official Publication Indian Soc Crit Care Med"},{"issue":"3","key":"13749_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1148\/rg.2020190156","volume":"40","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, Yeldandi A, Savas H, Parekh ND, Lombardi PJ, Hart EM. Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic correlation. Radiographics. 2020;40(3):656\u201366.","journal-title":"Radiographics"},{"issue":"4","key":"13749_CR23","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","volume":"15","author":"AK Singh","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metabolic Syndrome: Clin Res Reviews. 2021;15(4):102146. https:\/\/doi.org\/10.1016\/j.dsx.2021.05.019.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"13749_CR24","unstructured":"Centers for Disease Control and Prevention (CDC), Mucormycosis, Clinical Overview of Mucormycosis, updated April 24. 2024. Available from: https:\/\/www.cdc.gov\/mucormycosis\/hcp\/clinical-overview\/index.html (Accessed on 24.11.2024)."},{"key":"13749_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26\u201334.","journal-title":"Clin Microbiol Infect"},{"key":"13749_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoy iannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012a;54:23\u201334. https:\/\/doi.org\/10.1093\/cid\/cir866.","journal-title":"Clin Infect Dis"},{"key":"13749_CR27","doi-asserted-by":"publisher","unstructured":"Khanna M, Challa S, Kabeil AS, Inyang B, Gondal FJ, Abah GA, et al. Risk of mucormycosis in diabetes mellitus: a systematic review. Cureus. 2021 Oct 16;13(10):e18827. https:\/\/doi.org\/10.7759\/cureus.18827.","DOI":"10.7759\/cureus.18827"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13749-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:52:14Z","timestamp":1784548334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13749"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13749-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the National Centre for Disease Control Ethics Review Committee (NCDC-ERC), New Delhi, India (Approval No. NCDC\/NERC\/2024\/Research Protocol\/003) dated July 31, 2024. All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and\/ or national research committee and with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants included in the study. Participants were volunteers, and they were informed about the study objectives, procedures, potential risks and benefits prior to enrolment. Confidentiality of all participant information was maintained throughout the study.","order":3,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","label":"Consent to participant","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1370"}}